biotech · TCR-T Cells · B-ALL · TCRX
TScan Therapeutics
TScan Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2018
- Employees
- 152
- Programs
- 9
- Drugs
- 5
- Patents
- 0
TScan Therapeutics clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to TScan Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
TScan Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for TScan Therapeutics.
-
SOC + TSC-100 — Phase 1
Clinical update -
Tcrx T cell — Phase 1
Clinical update -
KXV01 TCR Lentinvivo Injection — Phase 1
Clinical update -
KSX01-TCRT injection — Phase 1
Clinical update -
KSV01 Injection — Phase 1
Clinical update -
KSV01 Injection — Phase 1
Clinical update -
KSH01 injection — Phase 1
Clinical update -
KSH01 injection — Phase 1
Clinical update